Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: A study of 25 consecutive patients and a literature review

Leukemia and Lymphoma

Volumn 48, Issue 2, 2007, Pages 321-329

  Micol, J B ^a   Berthon, C ^a   Tricot, S ^a   Terriou, L ^a   Darre S ^a   Cracco, P ^a   Boulanger, F ^a   Bauters, F ^a   Jouet, J P ^a   Yakoub Agha, I ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; CYCLOSPORIN A; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEPRAZOLE; TOBRAMYCIN; VALACICLOVIR; ANTINEOPLASTIC AGENT; DNA (CYTOSINE 5) METHYLTRANSFERASE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; VIDARABINE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; BACTEREMIA; BLEEDING DISORDER; BLOOD GROUP ABO INCOMPATIBILITY; BODY WEIGHT DISORDER; CANCER MORTALITY; CANCER RELAPSE; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; DONOR SELECTION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEVER; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; NONMYELOABLATIVE CONDITIONING; OVERALL SURVIVAL; PERIPHERAL BLOOD STEM CELL; PNEUMOCYSTOSIS; PRIORITY JOURNAL; SEPSIS; SEPTICEMIA; STRESS ULCER; SURVIVAL RATE; THROMBOCYTOPENIA; TOXOPLASMOSIS; VEIN OCCLUSION; WEIGHT REDUCTION; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; BLOOD DISEASE; DRUG ANTAGONISM; DRUG EFFECT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; IMMUNOSUPPRESSIVE TREATMENT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY;

ADULT; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; SURVIVAL RATE; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 34247887534     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190601059688     Document Type: Article

References (28)

1. Baron, F., Maris, M. B., Sandmaier, B. M., Storer, B. E., Sorror, M. and Diaconescu, R. (2005) Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol, 23, pp. 1993-2003.
2. Champlin, R., Khouri, I., Komblau, S., Molidrem, J. and Giralt, S. (1999) Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect. Oncology (Williston Park), 13, pp. 621-628.
3. Georges, G. E., Maris, M., Sandmaier, B. M., Malone, D. G., Feinstein, L. and Niederweiser, D. (2002) Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases. Int J Hematol, 76, pp. 184-189.
4. Blanc, K Le, Remberger, M., Uzunel, M., Mattsson, J., Barkholt, L. and Ringden, O. (2004) A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation. Transplantation, 78, pp. 1014-1020.
5. Maloney, D. G., Molina, A. J., Sahebi, F., Stockerl-Goldstein, K. E., Sandmaier, B. M. and Bensinger, W. (2003) Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood, 102, pp. 3447-3454.
6. Maris, M. B., Sandmaier, B. M., Storer, B. E., Chauncey, T., Stuart, M. J. and Maziarz, R. T. (2004) Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Blood, 104, pp. 3535-3542.
7. Niederwieser, D., Maris, M., Shizuru, J. A., Petersdorf, E., Hegenbart, U. and Sandmaier, B. M. (2003) Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood, 101, pp. 1620-1629.
8. Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M. and Cividalli, G. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 91, pp. 756-763.
9. Sorror, M. L., Maris, M. B., Sandmaier, B. M., Storer, B. E., Stuart, M. J. and Hegenbart, U. (2005) Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. J Clin Oncol, 23, pp. 3819-3829.
10. Przepiorka, D., Weisdorf, D., Martin, P., Klingemann, H. G., Beatty, P. and Hows, J. (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant, 15, pp. 825-828.
11. McSweeney, P. A., Niederwieser, D., Shizuru, J. A., Sandmaier, B. M., Molina, A. J. and Maloney, D. G. (2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood, 97, pp. 3390-3400.
12. Worel, N., Greinix, H. T., Keil, F., Mitterbauer, M., Lechner, K. and Fischer, G. (2002) Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion, 42, pp. 1293-1301.
13. Lapierre, V., Kuentz, M. and Tiberghien, P. (2000) Allogeneic peripheral blood hematopoietic stem cell transplantation: Guidelines for red blood cell immuno-hematological assessment and transfusion practice. Societe Francaise de Greffe de Moelle. Bone Marrow Transplant, 25, pp. 507-512.
14. Antin, J. H., Childs, R., Filipovich, A. H., Giralt, S., Mackinnon, S. and Spitzer, T. (2001) Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant, 7, pp. 473-485.
15. Childs, R., Clave, E., Contentin, N., Jayasekera, D., Hensel, N. and Leitman, S. (1999) Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses. Blood, 94, pp. 3234-3241.
16. Alizadeh, M., Bernard, M., Danic, B., Dauriac, C., Birebent, B. and Lapart, C. (2002) Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood, 99, pp. 4618-4625.
17. Kaplan, E. and Meier, P. (1958) Non parametric estimation from incomplete observations. J Am Stat Assoc, 53, pp. 457-481.
18. Peto, R. and Peto, J. (1972) Asymptotically efficient rank invariant test procedures. J R Stat Soc, 135, pp. 185-206.
19. Junghanss, C., Marr, K. A., Carter, R. A., Sandmaier, B. M., Maris, M. B. and Maloney, D. G. (2002) Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: A matched control study. Biol Blood Marrow Transplant, 8, pp. 512-520.
20. Svahn, B. M., Ringden, O. and Remberger, M. (2005) Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant, 36, pp. 511-516.
21. Weissinger, F., Sandmaier, B. M., Maloney, D. G., Bensinger, W. I., Gooley, T. and Storb, R. (2001) Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings. Blood, 98, pp. 3584-3588.
22. Beelen, D. W., Elmaagacli, A., Muller, K. D., Hirche, H. and Schaefer, U. W. (1999) Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: Final results and long-term follow-up of an open-label prospective randomized trial. Blood, 93, pp. 3267-3275.
23. Keil, F., Prinz, E., Moser, K., Mannhalter, C., Kalhs, P. and Worel, N. (2003) Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival. Transplantation, 76, pp. 230-236.
24. Baron, F., Baker, J. E., Storb, R., Gooley, T. A., Sandmaier, B. M. and Maris, M. B. (2004) Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood, 104, pp. 2254-2262.
25. Panse, J. P., Heimfeld, S., Guthrie, K. A., Maris, M. B., Maloney, D. G. and Baril, B. B. (2005) Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning. Br J Haematol, 128, pp. 659-667.
26. Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N. and Greimers, R. (2002) Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. J Hematother Stem Cell Res, 11, pp. 301-314.
27. Cao, T. M., Shizuru, J. A., Wong, R. M., Sheehan, K., Laport, G. G. and Stockerl-Goldstein, K. E. (2005) Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. Blood, 105, pp. 2300-2306.
28. Mohty, M., Bagattini, S., Chabannon, C., Faucher, C., Bardou, V. J. and Bilger, K. (2004) CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation. Exp Hematol, 32, pp. 1097-1102.